Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study
- Resource Type
- Article
- Source
- In
Annals of Oncology August 2004 15(8):1173-1178 - Subject
- Language
- ISSN
- 0923-7534